Mucosal peptic activity during Helicobacter pylori infection in pediatric patients

J Yahav1, G Oderda, A Diver-Haber

  • 1Pediatric Gastroenterology Service, Department of Clinical Microbiology, Tel Hashomer, Israel.

Gut
|September 1, 1992
PubMed

Insights

Helicobacter pylori infection reduces activated pepsinogen in pediatric gastritis patients. Antibiotic treatment restored pepsinogen levels, suggesting local pepsin inactivation or enhanced removal in H. pylori positive stomachs.

Area of Science:

  • Gastroenterology
  • Microbiology

Background:

  • Peptic activity within the gastric mucosa may contribute to gastritis.
  • Helicobacter pylori (H. pylori) infection is a common cause of gastritis.

Purpose of the Study:

  • To investigate intramucosal peptic activity in pediatric patients with H. pylori infection.
  • To determine the effect of H. pylori on pepsinogen activation in the gastric mucosa.

Main Methods:

  • Measurement of total peptic activity and activated pepsinogen in gastric and duodenal biopsies from pediatric patients.
  • Comparison of peptic activity in H. pylori positive patients, H. pylori negative gastritis patients, and controls.
  • Re-evaluation of peptic activity after antibiotic therapy in H. pylori positive patients.

Main Results:

  • Activated pepsinogen was significantly reduced in the stomach of H. pylori positive patients.
  • Pepsinogen levels were similar across all tested anatomical areas and patient groups.
  • Antibiotic therapy in H. pylori positive patients led to a significant increase in antral mucosal activated pepsinogen.

Conclusions:

  • Decreased activated pepsinogen in H. pylori positive gastritis suggests local pepsin inactivation or enhanced clearance.
  • Restoration of activated pepsinogen after treatment supports a direct role for H. pylori in altering mucosal peptic activity.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...